Leveraging Clinical Data to Evaluate a Single Dose Intravitreal Administration of AVD-104
Time: 2:00 pm
day: Clinical PM -Day 1
Details:
- Assessing the dose escalation and safety data
- Highlighting the benefits of using our chosen molecule
- Outlining the trial design for the 2 year trial with a 12 month primary endpoint
